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This is a personal story about how to get
your scientific career started with a bang.
It may not be as easy today as it was in the
1960s, but I think the principles still apply.
I hope that this personal recounting will be
useful to young scientists trying to establish
their career.
GET INTO A GOOD LABORATORY AS
SOON AS YOU CAN
The way to get your scientific career started
is to work with great scientists who are
working on important problems in an
exciting environment. I spent the sum-
mer of 1964 working as a technician in
the laboratory of Brigitta Askonas at the
National Institute for Medical Research
(NIMR) in Mill Hill, a northwest suburb
of London. Askonas was a rigorous sci-
entist who was interested in the role of
macrophages in the antibody response (1).
The job had been arranged by Charles
Medawar, a friend during my undergrad-
uate days at Indiana University (IU), and
son of Sir Peter Medawar, who was then
the Director of the NIMR and a Nobel
Laureate for the discovery of immune tol-
erance. It helped that I had worked in the
laboratory of Felix Haurowitz at IU study-
ing rabbit antibody responses to closely
related haptens, and thus had some intro-
duction to the field of immunology, and
that Professor Haurowitz was friends with
Sir Peter. So before I arrived at the Uni-
versity of Chicago to begin medical school
in the fall of 1965, I had spent time with
three prominent immunologists and I had
some sense of the critical issues in the
field and felt comfortable at the lab bench.
This was just after thymus-derived (T)
cells and bone marrow-derived (B) cells
had been identified (2), and the cellular
requirements for antibody formation were
still unknown.
FIND GOOD MENTORS AND DO NOT
GET DISCOURAGED IF AT FIRST YOU DO
NOT SUCCEED
My first year in medical school was a
disappointment. I liked the excitement
of a research lab, not the rote learning
of anatomy, physiology, and biochemistry.
During the spring of 1966, I remember
attending a lecture by Don Rowley and
being impressed by his enthusiasm and
energy. I decided to take a leave of absence
from medical school to pursue a Ph.D.
(this was prior to the combined M.D./Ph.D.
training program). Since Don Rowley and
Frank Fitch were in the Department of
Pathology, that was my first choice of grad-
uate department. Bob Wissler was then
chair of the department and I was assigned
by him to a new junior faculty member that
left me with lots of lab space and little men-
toring. I attempted, at first on my own, to
follow up on two seminal technical publica-
tions that had appeared in 1963 and 1966.
The first was the report by Neils Jerne and
Al Nordin (3) that described a method for
detecting single antibody-producing cells
by a hemolytic plaque assay using sheep
red blood cells (SRBC) as the antigen. The
second was the report by Bob Mishell and
Dick Dutton (4) describing in vitro anti-
body formation against SRBC in mouse
spleen cell cultures. My lab notebook from
1966 records many attempts to perfect the
Jerne plaque assay, at least some of which
were successful, and more attempts to per-
fect the Mishell–Dutton technique, none
of which were successful. I was spending
more time talking with Rowley and Fitch
trying to solve these problems. They were
an ideal team of mentors, with Rowley con-
stantly getting excited about the hypothesis
of the day, and Frank Fitch gently guid-
ing the experimental details in his gentle-
manly fashion. In January of 1967, they
proposed the brilliant idea of sending me
to Dutton’s lab at the Research Institute
of Scripps Clinic (now renamed as The
Scripps Research Institute, where I have
been since 1992) in La Jolla, CA, USA. A
trip from midwinter Chicago to sunny La
Jolla seemed like a great idea to me. Bob
Mishell and Dick Dutton were very cordial
hosts (Dick Dutton is a lifelong friend), and
I learned all the secrets of the culture tech-
nique that were not revealed in their paper,
such as, only selected sources of SRBC and
fetal calf serum would work, the rabbit
complement for developing the hemolytic
plaques needed to come from the right rab-
bit, and adding new medium to the cultures
each day was essential. They also showed
me their plastic culture boxes that were
much easier to use for the required gas mix-
ture than the desiccator jars that I had been
using in Chicago (I still have several of these
culture boxes in my lab these many years
later). I was able to take this information
back to Chicago and finally achieve success
by mid-March of 1967, with literally hun-
dreds of plaque-forming cells (PFC) per
million mouse spleen cells cultured.
ASK IMPORTANT QUESTIONS
One of the critical questions in immunol-
ogy was the role of “macrophages” in
the antibody response. Several papers had
suggested that incubation of macrophages
with antigen enhanced the immune
response when the mixture was injected
into animals, but their role in promoting
antibody formation was unknown at the
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time. There were some crazy (in retro-
spect) theories floating around, like RNA
from macrophages instructing B cells to
make antibody (better not cited). This was
long before we knew how antibody vari-
ability was generated, and instructional
theories of antibody folding favored by
Felix Haurowitz still had many proponents.
The new Mishell–Dutton culture technique
provided the opportunity to address the
role of macrophages in vitro since inspec-
tion of the tissue culture dishes by phase
microscopy (I was lucky to be in a pathol-
ogy department) clearly showed large,
adherent phagocytic cells that were often
surrounded by loosely or non-adherent
mouse splenic lymphocytes1. It was known
at the time that macrophages would adhere
to glass (5), but adherence to plastic cul-
ture dishes was a novel observation. My
lab notebook shows several experiments
where spleen cells were separated into
“sticky” and “non-sticky” cells, then later
revised to “adherent” and “non-adherent”
cells, and a final nomenclature evolution to
“macrophage-rich” and “lymphocyte-rich”
during the preparation of my 1967 man-
uscript (6). It was apparent by late April
of 1967 that neither “macrophage-rich” or
“lymphocyte-rich” spleen cell subpopula-
tions alone could respond to SRBC, but
adding SRBC to the “macrophage-rich”
subpopulation for 30 min prior to recom-
bining with the “lymphocyte-rich” sub-
population allowed a robust PFC response
that was comparable to intact spleen cells.
Experiments were numbered sequentially
in my notebook, and the productive repli-
cate experiments in April to June 1967 were
numbered 29–36, each involving 4–5 days
of culture before the Jerne PFC assays. For
young scientists starting out, it is worth
noting that most of the first 25 experiments
performed over a period of 8 months were
not productive, so be patient, seek help, and
collaborate with experts.
ACCEPT HELP GRACIOUSLY
Speaking of large numbers of experiments,
there were also large numbers of man-
uscript drafts over the summer of 1967
before the final version was submitted to
Science in October. This was my first paper,
and I spent many hours with Don Row-
ley refining each word in the manuscript,
shortening it to reach the word limit for Sci-
ence, hand drawing Figures 1 and 2 in India
ink (I still have the faded original Figure 1
in my notebook), and refining the technical
notes that would now appear as supple-
mental information but were then included
in the references. Frank Fitch also reviewed
the manuscript, but it was Don Rowley who
insisted that it meets his high standards –
the 30th revision finally made the cut. After
all this effort, I was amazed that both Don
Rowley and Frank Fitch insisted that they
should not be co-authors. This was gener-
ous by the standards of the day, and would
be next to impossible in the current cli-
mate of underfunded scientists scrambling
for NIH grants.
Subsequent work that I performed in
Don Rowley’s laboratory suggested that
the cell required for the SRBC antibody
response in the “macrophage-rich” sub-
population was quite rare (7) and unlikely
to be the predominant macrophage. This
led to a reversion of the nomenclature to
“adherent” cell, and later work by Ralph
Steinman identified the key adherent cell
to be the dendritic cell. Once again, Row-
ley and Fitch declined to be co-authors
on my paper, but the mathematician who
was familiar with limiting dilution analy-
sis, Lionel Coppleson, was appropriately
acknowledged. In 1969, I was convinced to
return to medical school, but I continued
to work part-time in the Rowley lab with
fellow students Jeffrey Roseman, Lee Leser-
man, and Bob Waterston. Great times in a
great laboratory! When I finished medical
school, I went back to Mill Hill for a short
but intense post-doc training with Avrion
Mitchison, where I met Martin Raff and
Harvey Cantor, and enjoyed many hours
of discussion and a few hours at the bench.
In retrospect, my first paper was one
of my best, and helped establish the
concept that antibody production by B
cells was dependent upon cell coopera-
tion between antigen-presenting cells and
the responding lymphocytes. Subsequent
work (7, 8) showed that T helper cells were
also required for the antibody response,
with the last paper finally including Frank
Fitch and Don Rowley2 as co-authors. This
requirement for three cell types had been
predicted by the limiting dilution exper-
iments (7), and led to much subsequent
work by many immunologists on antigen-
processing, helper T cell function, and the
genetic basis for antigen recognition by T
cells and B cells.
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1Rowley and Fitch had been studying antibody responses in rats in vivo, but we were never able to adopt the Mishell–Dutton technique to work with rat spleen cells in
culture.
2Sadly, Donald Adams Rowley died in February of 2013, and I was one of many of his former students who gathered in Chicago to pay tribute to him last spring. This
article is dedicated to him, a generous and skilled mentor whose contribution to the start of my career was unique and is appreciated more with each passing year.
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